Bioavailability and kinetics of the antihypertensive casein-derived peptide HLPLP in rats

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 49, 2014, Pages 11869-11875

  Sánchez Rivera, Laura ^a   Ares, Irma ^b   Miralles, Beatriz ^a   Gómez Ruiz, José Ángel ^a   Recio, Isidra ^a   Martínez Larrañaga, María Rosa ^b   Anadón, Arturo ^b   Martínez, María Aránzazu ^b  

^a INSTITUTE OF FOOD SCIENCE RESEARCH CIAL   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

antihypertensive peptide HLPLP; oral bioavailability; plasma disposition; rats; tandem MS

Indexed keywords

ANTHROPOMETRY; BIOCHEMISTRY; CASEIN; KINETIC THEORY; KINETICS; LIQUID CHROMATOGRAPHY; PEPTIDES; RATING;

ANTIHYPERTENSIVE EFFECT; ANTIHYPERTENSIVE PEPTIDES; DOSE RESPONSE RELATIONSHIPS; INTRAVENOUS ADMINISTRATION; ORAL BIOAVAILABILITIES; SPONTANEOUSLY HYPERTENSIVE RATS; TANDEM MS; ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHIES;

RATS;

RATTUS;

ANTIHYPERTENSIVE AGENT; CASEIN; PEPTIDE;

ANIMAL; BIOAVAILABILITY; BLOOD; CHEMISTRY; HALF LIFE TIME; HUMAN; HYPERTENSION; KINETICS; MALE; ORAL DRUG ADMINISTRATION; RAT; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL AVAILABILITY; CASEINS; HALF-LIFE; HUMANS; HYPERTENSION; KINETICS; MALE; PEPTIDES; RATS; RATS, WISTAR;

EID: 84916618628     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf5035256     Document Type: Article

References (25)

1. Fitzgerald, R. J.; Murray, B. A. Bioactive peptides and lactic fermentations Int. J. Dairy Technol. 2006, 59, 118-125
2. Korhonen, H.; Pihlanto, A. Bioactive peptides: Production and functionality Int. Dairy J. 2006, 16, 945-960
3. Martínez-Maqueda, D.; Miralles, B.; Recio, I.; Hernández-Ledesma, B. Antihypertensive peptides from food proteins: a review Food Funct. 2012, 3, 350-361
4. García-Tejedor, A.; Sánchez-Rivera, L.; Castelló-Ruiz, M.; Recio, I.; Salom, J.; Manzanares, P. Novel antihypertensive lactoferrin-derived peptides produced by Kluyveromyces marxianus: Gastrointestinal stability profile and in vivo angiotensin I-converting enzyme (ACE) inhibition J. Agric. Food Chem. 2014, 62, 1609-1616
5. Muguerza, B.; Ramos, M.; Sánchez, E.; Manso, M. A.; Miguel, M.; Aleixandre, A.; Delgado, M. A.; Recio, I. Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk Int. Dairy J. 2006, 16, 61-69
6. Miguel, M.; Muguerza, B.; Sánchez, E.; Delgado, M. A.; Recio, I.; Ramos, M.; Aleixandre, M. A. Changes in arterial blood pressure in hypertensive rats caused by long-term intake of milk fermented by Enterococcus faecalis CECT 5728 Br. J. Nutr. 2005, 94, 36-43
7. Miguel, M.; Recio, I.; Ramos, M.; Delgado, M. A.; Aleixandre, M. A. Antihypertensive effect of peptides obtained from Enterococcus faecalis -fermented milk in rats J. Dairy Sci. 2006, 89, 3352-3359
8. Quirós, A.; Contreras, M. d. M.; Ramos, M.; Amigo, L.; Recio, I. Stability to gastrointestinal enzymes and structure-activity relationship of [beta]-casein-peptides with antihypertensive properties Peptides 2009, 30, 1848-1853
9. Quirós, A.; Dávalos, A.; Lasunción, M. A.; Ramos, M.; Recio, I. Bioavailability of the antihypertensive peptide LHLPLP: Transepithelial flux of HLPLP Int. Dairy J. 2008, 18, 279-286
10. Miguel, M.; Gómez-Ruiz, J. á.; Recio, I.; Aleixandre, A. Changes in arterial blood pressure after single oral administration of milk-casein-derived peptides in spontaneously hypertensive rats Mol. Nutr. Food Res. 2010, 54, 1422-1427
11. Quirós, A.; Hernández-Ledesma, B.; Ramos, M.; Martín-álvarez, P. J.; Recio, I. Production of antihypertensive peptide HLPLP by enzymatic hydrolysis: Optimization by response surface methodology J. Dairy Sci. 2012, 95, 4280-4285
12. Franz, C. M. A.; Huch, M.; Abriouel, H.; Holzapfel, W.; Gálvez, A. Enterococci as probiotics and their implications in food safety Int. J. Food Microbiol. 2011, 151, 125-140
13. Foltz, M.; van der Pijl, P. C.; Duchateau, G. S. M. J. E. Current in vitro testing of bioactive peptides is not valuable J. Nutr. 2010, 140, 117-118
14. van Platerink, C. J.; Janssen, H.-G. M.; Horsten, R.; Haverkamp, J. Quantification of ACE inhibiting peptides in human plasma using high performance liquid chromatography-mass spectrometry J. Chromatogr. B 2006, 830, 151-157
15. Matsui, T.; Tamaya, K.; Seki, E.; Osajima, K.; Matsumoto, K.; Kawasaki, T. Val-Tyr as a natural antihypertensive dipeptide can be absorbed into the human circulatory blood system Clin. Exp. Pharmacol. Physiol. 2002, 29, 204-208
16. Foltz, M.; Meynen, E. E.; Bianco, V.; van Platerink, C.; Koning, T. M. M. G.; Kloek, J. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation J. Nutr. 2007, 137, 953-958
17. van der Pijl, P.; Kies, A. K.; Ten Have, G. A. M.; Duchateau, G. S. M. J. E.; Deutz, E. P. Pharmacokinetics of proline-rich tripeptides in the pig Peptides 2008, 29, 2196-2202
18. Gomez-Ruiz, J. A.; Ramos, M.; Recio, I. Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures Int. Dairy J. 2002, 12, 697-706
19. Yamaoka, K.; Nakagawa, T.; Uno, T. Application of Akaike's Information Criterion (AIC) in the evaluation of linear pharmacokinetic equations J. Pharmacokinet. Biopharm. 1978, 6, 165-175
20. Wagner, J. G. Fundamentals of Clinical Pharmacokinetics; Drug Intelligence Publications: Hamilton, IL, 1975.
21. Wagner, J. G. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of poly-exponential equations which have been titled to the data J. Pharmacokinet. Biopharm. 1975, 4, 443-467
22. Papayannopoulos, I. A. The interpretation of collision-induced dissociation tandem mass spectra of peptides Mass Spectrom. Rev. 1995, 14, 49-73
23. EMEA (European Medicines Agency). CPMP/ICH/286/95 Guideline. Non-Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals; EMEA: London, 2008.
24. Li, Z.; Jiand, H.; Xu, C.; Gu, L. A review. Using nanoparticles to enhance absorption and bioavailability of phenolic phytochemicals Food Hydrocolloids 2014, 43, 153-164
25. Gao, S.; Hu, M. Bioavailability challenges associated with development of anti-cancer phenolic Mini-Rev. Med. Chem. 2014, 10, 550-567